Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oncological Outcomes of Stage II Endometrial Cancer: A Retrospective Analysis of 250 Cases.
Ozgul N, Boyraz G, Salman MC, Gultekin M, Yuce K, Ibrahimov A, Erturk A, Gungorduk K, Gulseren V, Sanci M, Turkmen O, Karalok A, Kimyon G, Turan T, Ozkan NT, Meydanli MM, Gungor T, Ayik H, Simsek T. Ozgul N, et al. Among authors: yuce k. Int J Gynecol Cancer. 2018 Jan;28(1):161-167. doi: 10.1097/IGC.0000000000001133. Int J Gynecol Cancer. 2018. PMID: 28930810
Extrauterine Spread, Adjuvant Treatment, and Prognosis in Noninvasive Uterine Papillary Serous Carcinoma of the Endometrium: A Retrospective Multicenter Study.
Boyraz G, Salman MC, Basaran D, Ozgul N, Turan T, Turkmen O, Kimyon GC, Ozkan NT, Cagan M, Gungor T, Meydanli MM, Gungorduk K, Gulseren V, Sanci M, Yuce K. Boyraz G, et al. Among authors: yuce k. Int J Gynecol Cancer. 2017 Jan;27(1):102-108. doi: 10.1097/IGC.0000000000000838. Int J Gynecol Cancer. 2017. PMID: 27668395
Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study.
Sarı ME, Meydanlı MM, Türkmen O, Cömert GK, Turan AT, Karalök A, Şahin H, Haberal A, Kocaman E, Akbayır Ö, Erdem B, Numanoğlu C, Güngördük K, Sancı M, Gökçü M, Özgül N, Salman MC, Boyraz G, Yüce K, Güngör T, Taşkın S, Altın D, Ortaç UF, Ayık HA, Şimşek T, Arvas M, Ayhan A. Sarı ME, et al. Among authors: yuce k. J Gynecol Oncol. 2017 Jul;28(4):e49. doi: 10.3802/jgo.2017.28.e49. J Gynecol Oncol. 2017. PMID: 28541637 Free PMC article.
Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone.
Topfedaisi Ozkan N, Meydanlı MM, Sarı ME, Demirkiran F, Kahramanoglu I, Bese T, Arvas M, Şahin H, Haberal A, Celik H, Coban G, Oge T, Yalcin OT, Akbayır Ö, Erdem B, Numanoğlu C, Özgül N, Boyraz G, Salman MC, Yüce K, Dede M, Yenen MC, Taşkın S, Altın D, Ortaç UF, Aydın Ayık H, Şimşek T, Güngör T, Güngördük K, Sancı M, Ayhan A. Topfedaisi Ozkan N, et al. Among authors: yuce k. J Gynecol Oncol. 2017 Sep;28(5):e65. doi: 10.3802/jgo.2017.28.e65. Epub 2017 Jun 16. J Gynecol Oncol. 2017. PMID: 28657226 Free PMC article.
What is the impact of stromal microinvasion on oncologic outcomes in borderline ovarian tumors? A multicenter case-control study.
Boyraz G, Salman MC, Gultekin M, Ozkan NT, Uckan HH, Gungorduk K, Gulseren V, Ayik H, Toptas T, Kuru O, Sozen H, Erturk A, Ozgul N, Meydanlı MM, Sanci M, Turan T, Gungor T, Simsek T, Topuz S, Yuce K. Boyraz G, et al. Among authors: yuce k. Arch Gynecol Obstet. 2017 Nov;296(5):979-987. doi: 10.1007/s00404-017-4496-4. Epub 2017 Sep 2. Arch Gynecol Obstet. 2017. PMID: 28866783
153 results